Home/Filings/4/0001209191-19-015914
4//SEC Filing

White David 4

Accession 0001209191-19-015914

CIK 0001175505other

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 6:21 PM ET

Size

7.5 KB

Accession

0001209191-19-015914

Insider Transaction Report

Form 4
Period: 2019-02-28
White David
See Remarks
Transactions
  • Award

    Common Stock

    2019-02-28+15,00015,000 total
  • Award

    Employee Stock Option (right to buy)

    2019-02-28+30,00030,000 total
    Exercise: $11.58Exp: 2029-02-27Common Stock (30,000 underlying)
Footnotes (2)
  • [F1]Represents shares of restricted stock, which will vest according to the following schedule: one-third (1/3) of the restricted stock will vest on each of February 28, 2020, 2021 and 2022, provided the reporting person provides services to Five Prime Therapeutics, Inc. (the "Company") through each such date.
  • [F2]One fourth (1/4) of the shares underlying this option will vest on February 28, 2020, and the remainder of the shares underlying this option will vest at a rate of one forty-eighth (1/48) per month thereafter, provided the reporting person provides services to the Company through each such date.

Issuer

FIVE PRIME THERAPEUTICS INC

CIK 0001175505

Entity typeother

Related Parties

1
  • filerCIK 0001329049

Filing Metadata

Form type
4
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 6:21 PM ET
Size
7.5 KB